Labs may blind the Clostridium difficile BioFire FilmArray GI Panel due to concerns about over-diagnosis, but that can lead to missed C. diff diagnoses, according to a study led by Ioannis M. Zacharioudakis, MD, of the New York University School of Medicine and published in Diagnostic Microbiology and Infectious Disease. "The practice of concealing C. difficile FilmArray GI Panel results needs to be re-considered in patients presenting with community-onset colitis," researchers wrote.
Study: Blinding C. diff panel may hinder diagnoses
Sign up for ACG SmartBrief
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.